cis(+/-)-3-(tert-Butoxycarbonyl)amino-1-(diphenylmethyl)-2-ethylazetidine → cis(+/-)-3-(tert-Butoxycarbonyl)amino-2-ethylazetidine
반응식
[C:1]([O:5][C:6]([NH:8][C@H:9]1[CH2:12][N:11](C(C2C=CC=CC=2)C2C=CC=CC=2)[C@H:10]1[CH2:26][CH3:27])=[O:7])([CH3:4])([CH3:3])[CH3:2]>[Pd]>[C:1]([O:5][C:6]([NH:8][C@H:9]1[CH2:12][NH:11][C@H:10]1[CH2:26][CH3:27])=[O:7])([CH3:4])([CH3:3])[CH3:2]참가 물질
3
실험 절차
The same operation as in Example (234e) was performed using cis(±)-3-(tert-butoxycarbonyl)amino-1-(diphenylmethyl)-2-ethylazetidine obtained in Example (235e) (154 mg, 0.42 mmol) and 10% Pd/C (30 mg), to obtain 66 mg of the title compound as a white solid (79%).
출처 및 근거
- ORD 기록
- ord-177e7e3a0665403b873de4cd572fc87b
- 출처 데이터셋
- uspto-grants-2015_01
- 특허 번호
- US08927588B2
반응 노트
불러오는 중…